MLchartDataset catalogue

paclitaxel polyglutamate

Term · Oncology and biomedicine · MLC-T-ONC-006246

A form of the anticancer drug paclitaxel combined with a protein called poliglumex that may have fewer side effects and work better than paclitaxel. It is being studied in the treatment of breast cancer, ovarian cancer, lung cancer, and other types of cancer. It belongs to the family of drugs called mitotic inhibitors. Also called CT-2103, paclitaxel poliglumex, and Xyotax.

Table 1. Record
IdentifierMLC-T-ONC-006246
FieldOncology and biomedicine
SynonymsCT-2103; paclitaxel poliglumex; Xyotax
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-006246",
  "term": "paclitaxel polyglutamate",
  "field": "Oncology and biomedicine",
  "definition": "A form of the anticancer drug paclitaxel combined with a protein called poliglumex that may have fewer side effects and work better than paclitaxel. It is being studied in the treatment of breast cancer, ovarian cancer, lung cancer, and other types of cancer. It belongs to the family of drugs called mitotic inhibitors. Also called CT-2103, paclitaxel poliglumex, and Xyotax.",
  "synonyms": [
    "CT-2103",
    "paclitaxel poliglumex",
    "Xyotax"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/paclitaxel-polyglutamate/"
}

Record 12,500 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.